Predictive Ability of a Predischarge Hour-specific Serum Bilirubin for Subsequent Significant Hyperbilirubinemia in Healthy Term and Near-term Newborns

Objective. To assess the predictive ability of a universal predischarge serum bilirubin measurement to screen for risk of subsequent significant hyperbilirubinemia in the direct Coombs negative healthy term and near-term newborn during the first postnatal week. Methods. Total serum bilirubin (TSB) levels were obtained at the time of the routine metabolic screen in all term and near-term newborns cared for in the Pennsylvania Hospital Well Baby Nursery (n = 13 003). Postnatal age (in hours) at the time of TSB measurement was recorded. A percentile-based bilirubin nomogram for the first week was constructed from hour-specific predischarge and postdischarge TSB values of newborns (n = 2840; median BW = 3230 g and median gestational age = 39 weeks) who met classification criteria for healthy newborns (excluding those with a positive direct Coombs test or those requiring phototherapy before age 60 hours) and who were enrolled in a hospital supervised home or outpatient follow-up program. The accuracy of the predischarge TSB as a predictor of subsequent degree of hyperbilirubinemia was determined. Results. The study patients in the nomogram were racially diverse. Nearly 60% were breastfed. Predischarge, 6.1% of the study population (172/2840) had TSB values in the high-risk zone (≥95th percentile) at 18 to 72 hours; of these, 39.5% (68/172) remained in that zone (likelihood ratio [LR] = 14.08, sensitivity = 54%; specificity = 96.2%, probability = 39.5%). Predischarge, 32.1% of the population (912/2840) had TSB values in the intermediate-risk zone. In a clinically significant minority of these newborns (58/912 or 6.4%), the postdischarge TSB moved into the high-risk zone (LR of this move: 3.2 from the upper-intermediate zone and .48 from the lower-intermediate risk zone). The predischarge TSB in 61.8% of the newborns (1756/2840) was in the low-risk zone (<40th percentile) and there was no measurable risk for significant hyperbilirubinemia (LR = 0, sensitivity = 100%; specificity = 64.7%; probability = 0%). Conclusions. An hour-specific TSB before hospital discharge can predict which newborn is at high, intermediate or low risk for developing clinically significant hyperbilirubinemia (specifically defined as TSB levels ≥95th percentile for age in hours). Risk designation and subsequent increases or decreases of in TSB can be easily monitored on an hour-specific percentile based predictive bilirubin nomogram. A predischarge TSB measured as a universal policy would facilitate targeted intervention and follow-up in a safe, cost-effective manner. In conjunction with bilirubin practice parameter of the American Academy of Pediatrics, it could reduce the potential risk for bilirubin-induced neurologic dysfunction.

[1]  R. Zamar,et al.  [HYPERBILIRUBINEMIA IN THE NEWBORN]. , 1963, Revista de la Facultad de Ciencias Medicas de Cordoba.

[2]  L I Kramer,et al.  Advancement of dermal icterus in the jaundiced newborn. , 1969, A M A Journal of Diseases of Children.

[3]  Phototherapy in the Newborn: An Overview , 1975 .

[4]  A. Feinstein,et al.  Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. , 1978, The New England journal of medicine.

[5]  R. Brodersen,et al.  Risk of bilirubin acid precipitation in preterm infants with respiratory distress syndrome: considerations of blood/brain bilirubin transfer equilibrium. , 1982, Early human development.

[6]  A. Albert,et al.  On the use and computation of likelihood ratios in clinical chemistry. , 1982, Clinical chemistry.

[7]  R. Schreiner,et al.  Interlaboratory bilirubin variability. , 1982, Pediatrics.

[8]  Y. Wax,et al.  Auditory nerve-brainstem evoked responses in hyperbilirubinemic neonates. , 1983, Pediatrics.

[9]  J. Hanley,et al.  Statistical Approaches to the Analysis of Receiver Operating Characteristic (ROC) Curves , 1984, Medical decision making : an international journal of the Society for Medical Decision Making.

[10]  R. Shimabuku,et al.  AUDITORY NERVE AND BRAINSTEM RESPONSES IN NEWBORN INFANTS WITH HYPERBILIRUBINEMIA , 1984, Pediatric Research.

[11]  D. Stevenson,et al.  Use of noninvasive tests to predict significant jaundice in full-term infants: preliminary studies. , 1985, Pediatrics.

[12]  K. Radack,et al.  The likelihood ratio. An improved measure for reporting and evaluating diagnostic test results. , 1986, Archives of pathology & laboratory medicine.

[13]  The laboratory method as a variable in the diagnosis of hyperbilirubinemia. , 1987, American journal of diseases of children.

[14]  L. D. de Vries,et al.  Relationship of serum bilirubin levels and hearing impairment in newborn infants. , 1987, Early human development.

[15]  S. Dollberg,et al.  Epidemiology of Neonatal Jaundice in the Jerusalem Population , 1990, Journal of pediatric gastroenterology and nutrition.

[16]  D. Stevenson,et al.  Laboratory evaluation of jaundice in newborns. Frequency, cost, and yield. , 1990, A M A Journal of Diseases of Children.

[17]  M. J. Maisels,et al.  Does hyperbilirubinemia damage the brain of healthy full-term infants? , 1990, Clinics in perinatology.

[18]  Bilirubin toxicity: pathophysiology and assessment of risk factors. , 1991, New York state journal of medicine.

[19]  L. Johnson Hyperbilirubinemia in the term infant: when to worry, when to treat. , 1991, New York state journal of medicine.

[20]  L. Johnson Yet another expert opinion on bilirubin toxicity. , 1992, Pediatrics.

[21]  L. Gartner Management of jaundice in the well baby. , 1992, Pediatrics.

[22]  D. Stevenson,et al.  Jaundice in healthy, term neonates: do we need new action levels or new approaches? , 1992, Pediatrics.

[23]  W. Cashore Hyperbilirubinemia: should we adopt a new standard of care? , 1992, Pediatrics.

[24]  T B Newman,et al.  Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. , 1992, Pediatrics.

[25]  In search of a 'gold standard' for bilirubin toxicity. , 1992, Pediatrics.

[26]  R. Wennberg Bilirubin recommendations present problems: new guidelines simplistic and untested. , 1992, Pediatrics.

[27]  R. Brand,et al.  Hyperbilirubinemia in low birth weight infants and outcome at 5 years of age. , 1992, Pediatrics.

[28]  T. Valaes Bilirubin toxicity: the problem was solved a generation ago. , 1992, Pediatrics.

[29]  M. J. Maisels,et al.  Hyperbilirubinemia in the breast-fed newborn: a controlled trial of four interventions. , 1993, Pediatrics.

[30]  M. Klebanoff,et al.  Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. , 1993, Pediatrics.

[31]  Subcommittee on Hyperbilirubinemia Practice Parameter: Management of Hyperbilirubinemia in the Healthy Term Newborn , 1994, Pediatrics.

[32]  H. Tamai,et al.  Vigintiphobia, unbound bilirubin, and auditory brainstem responses. , 1994, Pediatrics.

[33]  C. Sumaya,et al.  Early discharge: in the end, it is judgment. , 1995, Pediatrics.

[34]  W. Moneit Kernicterus in a full-term infant: the need for increased vigilance. , 1995, Pediatrics.

[35]  H. Harcke,et al.  Ultrasound screening for dysplasia of the hip. , 1995, Pediatrics.

[36]  M. J. Maisels,et al.  Kernicterus in otherwise healthy, breast-fed term newborns. , 1995, Pediatrics.

[37]  K. Holden,et al.  Hemolytic jaundice due to G6PD deficiency causing kernicterus in a female newborn. , 1995, Southern medical journal.

[38]  P. Braveman,et al.  Early Discharge of Newborns and Mothers: A Critical Review of the Literature , 1995, Pediatrics.

[39]  P. Braveman,et al.  Problems associated with early discharge of newborn infants. Early discharge of newborns and mothers: a critical review of the literature. , 1995, Pediatrics.

[40]  T. Hansen Kernicterus in a full-term infant: the need for increased vigilance. , 1995, Pediatrics.

[41]  M. G. Macdonald,et al.  Hidden risks: early discharge and bilirubin toxicity due to glucose 6-phosphate dehydrogenase deficiency. , 1995, Pediatrics.

[42]  C. Boesch,et al.  Regional Metabolic Assessment of Human Brain during Development by Proton Magnetic Resonance Spectroscopy In Vivo and by High-Performance Liquid Chromatography/Gas Chromatography in Autopsy Tissue , 1995, Pediatric Research.

[43]  V. Bhutani,et al.  PROBABILITY OF SUBSEQUENT HYPERBILIRUBINEMIA IN TERM HEALTHY NEWBORNS WITH NO ABO/Rh DISEASE. † 1165 , 1996, Pediatric Research.

[44]  J. Tyson,et al.  Interlaboratory variability of bilirubin measurements. , 1996, Clinical chemistry.

[45]  CAN BILIRUBIN LEVELS AT AGE ≤ 24 HOURS PREDICT THE RISK OF NEONATAL JAUNDICE? † 1451 , 1996, Pediatric Research.

[46]  A. Christensen [Kernicterus in a full term infant]. , 1996, Ugeskrift for laeger.

[47]  A. Brown Loss of concern about jaundice and the reemergence of kernicterus in full term infants in the era of managed care , 1996 .

[48]  A. Knudsen Prediction and non‐invasive assessment of neonatal jaundice in the term healthy newborn infant , 1996, Acta paediatrica.

[49]  ROUTINE SCREENING EYE EXAMS ARE ASSOCIATED WITH INCREASED FEEDING PROBLEMS IN PRETERM INFANTS. † 1168 , 1996, Pediatric Research.

[50]  P. Braveman,et al.  Early discharge and evidence-based practice. Good science and good judgment. , 1997, JAMA.

[51]  G. Gourley Bilirubin metabolism and kernicterus. , 1997, Advances in pediatrics.

[52]  D K Stevenson,et al.  Carbon monoxide and bilirubin production in neonates. , 2001, Seminars in perinatology.

[53]  M. J. Maisels,et al.  Jaundice in full-term and near-term babies who leave the hospital within 36 hours. The pediatrician's nemesis. , 1998, Clinics in perinatology.

[54]  V. Bhutani,et al.  Guidelines for management of the jaundiced term and near-term infant. , 1998, Clinics in perinatology.

[55]  R. Birnbacher,et al.  Does cigarette-smoking cause intrauterine growth retardation by decreasing fetal IGF-I? 971 , 1998, Pediatric Research.

[56]  V. Bhutani,et al.  Non-Invasive Measurement of Total Serum Bilirubin by Multi-Wavelength Spectral Reflectance by Bili Check (TM) in Newborn Patients † 968 , 1998, Pediatric Research.